Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 15Prostatic Neoplasms 10Neoplasms 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Myeloid, Acute 4Triple Negative Breast Neoplasms 3Ovarian Neoplasms 3Myelodysplastic Syndromes 3Endometrial Neoplasms 3Colorectal Neoplasms 3Colonic Neoplasms 3Cardiovascular Diseases 3Cardiotoxicity 3Rectal Neoplasms 2Polycystic Ovary Syndrome 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Melanoma 2Lymphoma, Non-Hodgkin 2Leukemia 2Kidney Neoplasms 2Heart Failure 2Head and Neck Neoplasms 2Glioblastoma 2Endometrial Hyperplasia 2Carcinoma, Renal Cell 2Waldenstrom Macroglobulinemia 1Venous Thrombosis 1Urogenital Neoplasms 1Smoking 1

Interventions

Tamoxifen 4Exercise 3pyrotinib 2abemaciclib 2Paclitaxel 2Metformin 2Letrozole 2Cyclophosphamide 2Control Groups 2Capecitabine 2Bupivacaine 2Aromatase Inhibitors 2pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1palbociclib 1iniparib 1exemestane 1durvalumab 1darolutamide 1Yoga 1Waiting Lists 1Vitamin D 1Tumor Burden 1Tretinoin 1Trastuzumab 1Tocopherols 1Thioctic Acid 1Surveys and Questionnaires 1Surgical Procedures, Operative 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Cancer Female × Atorvastatin × Clear all
NCT05507398 2022-10-31

The Anti-tumor Effect of Metformin And Atorvastatin in Breast Cancer

Tanta University

Phase 4 Unknown
100 enrolled
Breast

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon âš¡